Kevin L. Law

Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine

David M. Bender, Jingqi Bao, Anne H. Dantzig et al. · Journal of Medicinal Chemistry · 2009 · 107 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +14

Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein

James J. Starling, Robert L. Shepard, Jin Cao et al. · Advances in Enzyme Regulation · 1997 · 86 citations

Molecular Pharmacology, Pharmacological Characterization, Biochemistry +6

Acyl Sulfonamide Anti-Proliferatives:  Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents

Karen L. Lobb, Philip A. Hipskind, James Aikins et al. · Journal of Medicinal Chemistry · 2004 · 67 citations · Full text

Organic Chemistry, Chemistry, Human Tumor Xenografts +16

Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)

Bryan H. Norman, Joseph M. Gruber, Sean P. Hollinshead et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 66 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +11

Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.

Damon L. Meyer, Louis N. Jungheim, Kevin L. Law et al. · PubMed · 1993 · 62 citations

Engineering, Immunology, Tumor Biology +19